paid-clinical-trial | Media Room

Press Release Oct 17, 2012

New Phase II Paid Diabetes Clinical Trial Now Enrolling at Achieve Clinical Research; Accepting M/F Age 18-70 with Type 2 Diabetes

The primary objective of this 22 week study is to investigate the change in glycosylated hemoglobin (HbA1c) after receiving the new drug, as compared to those receiving a placebo.

New Phase 3 Paid Lower Back Pain Clinical Trial Now Enrolling at Avail Clinical Research in Central Florida; Accepting Male & Female Participants Age 18-75

The primary objective of this study is to evaluate the efficacy of a new drug compared with a placebo in opioid-experienced and opioid-naive subjects with moderate-to-severe Chronic Lower Back Pain.

New Phase 2 Paid Hepatitis C Clinical Trial Now Enrolling at Avail Clinical Research in Central Florida; Accepting Male & Female Participants Age 18-70

The primary objectives of this study are to evaluate the 12-week safety, antiviral activity and tolerability of this new Hep C drug when given in combination with PEG and RIBA as measured by extended rapid virologic response.